Ahmad Yousif, Agarwal Vratika, Williams Matthew L, Wang Dee Dee, Reardon Michael J, Cavalcante João L, Makkar Raj, Forrest John K
Division of Cardiology, Yale School of Medicine, Yale University, New Haven, Connecticut.
Division of Cardiac Surgery, Yale School of Medicine, Yale University, New Haven, Connecticut.
J Soc Cardiovasc Angiogr Interv. 2022 Oct 11;1(6):100506. doi: 10.1016/j.jscai.2022.100506. eCollection 2022 Nov-Dec.
Transcatheter aortic valve replacement has emerged as a safe and effective alternative to surgical aortic valve replacement for patients with severe symptomatic aortic stenosis across the spectrum of surgical risks based on a series of foundational randomized clinical trials. Of note, patients with bicuspid aortic valve (BAV) disease were excluded from all these pivotal randomized trials, leaving a significant knowledge gap because BAVs are commonly encountered in patients referred for aortic valve surgery or intervention. In this comprehensive review, we aim to provide heart teams with a detailed insight into how to approach patients with BAV disease, focusing on imaging and characterization of bicuspid valves, an overview of surgical approaches, and an understanding of the current data behind the role of transcatheter aortic valve replacement for patients with BAV disease.
基于一系列基础随机临床试验,经导管主动脉瓣置换术已成为手术风险各异的重度症状性主动脉瓣狭窄患者进行外科主动脉瓣置换的一种安全有效的替代方法。值得注意的是,所有这些关键随机试验均排除了患有二叶式主动脉瓣(BAV)疾病的患者,这造成了重大的知识空白,因为BAV在接受主动脉瓣手术或干预的患者中很常见。在这篇全面综述中,我们旨在为心脏治疗团队提供关于如何治疗BAV疾病患者的详细见解,重点关注二叶式瓣膜的成像和特征、手术方法概述以及对经导管主动脉瓣置换术在BAV疾病患者中作用的现有数据的理解。